Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

novartis

This study aims to assess the new film-coated tablet formulation to the currently approved dispersible tablet formulation with regards to overall safety, Gastrointestinal (GI) tolerability, palatability, satisfaction and compliance.

More information: clinicaltrials.gov, ITHANET Clinical Trials